Preliminary experiences using the MGuard stent platform in saphenous vein graft lesions.
The MGuard stent has been designed as a plaque trapping device to treat athero-thrombotic lesions in saphenous vein grafts and native coronary lesions. It was utilized in seven coronary bypass patients to treat eight vein grafts. The average graft age was 15 years. Procedural success was 100% without any intraprocedural, in-hospital, and/or 30-day major adverse cardiac events (e.g. death, myocardial infarction, and need for repeat graft revascularization). No patient experienced distal embolization and/or procedure-related CK enzymatic rise. This strategy seems to be a promising approach in percutaneous vascular management of vein graft lesions.
Vaknin-Assa
Hana
H
Division of Interventional Cardiology, Rabin Medical Center, Petach Tikva, and Sackler Faculty of Medicine, Tel-Aviv University, Israel.
Assali
Abid
A
Kornowski
Ran
R
D000368:Aged; D000369:Aged, 80 and over; D015906:Angioplasty, Balloon, Coronary / Q000295:instrumentation*; D017023:Coronary Angiography; D001026:Coronary Artery Bypass / Q000009:adverse effects*; D005260:Female; D006083:Graft Occlusion, Vascular / Q000000981:diagnostic imaging / Q000209:etiology / Q000628:therapy*; D006801:Humans; D008297:Male; D010865:Pilot Projects; D011474:Prosthesis Design; D012501:Saphenous Vein / Q000000981:diagnostic imaging / Q000637:transplantation*; D015607:Stents; D013997:Time Factors; D016896:Treatment Outcome